GM03332
LCL from B-Lymphocyte
Description:
ATAXIA-TELANGIECTASIA; AT
ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers Chromosome Abnormalities |
Class |
Repair Defective and Chromosomal Instability Syndromes |
Class |
Syndromes with Increased Chromosome Breakage |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
Black/African American
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a positive result with a primer for Yq11, DYS227. |
|
Gene |
ATM |
Chromosomal Location |
11q22.3 |
Allelic Variant 1 |
W2638X; ATAXIA-TELANGIECTASIA |
Identified Mutation |
TRP2638TER |
|
Gene |
ATM |
Chromosomal Location |
11q22.3 |
Allelic Variant 2 |
W2638X; ATAXIA-TELANGIECTASIA |
Identified Mutation |
TRP2638TER |
Remarks |
Clinically affected; same donor as GM03395 Fibroblast; a deceased sister also had AT; lymphoid culture shows hypersensitivity to X-irradiation; parents are GM03334 and GM03382; donor subject is homozygous for a G>A transition at nucleotide 7913 in exon 55 of the ATM gene (7913G>A) resulting in a substitution of a termination codon for tryptophan at codon 2638 [Trp2638Ter (W2638X)] |
Caballero M, Ge T, Rebelo AR, Seo S, Kim S, Brooks K, Zuccaro M, Kanagaraj R, Vershkov D, Kim D, Smogorzewska A, Smolka M, Benvenisty N, West SC, Egli D, Mace EM, Koren A, Comprehensive analysis of DNA replication timing across 184 cell lines suggests a role for MCM10 in replication timing regulation Human molecular genetics: 2021 |
PubMed ID: 35394024 |
|
Loke J, Alim I, Yam S, Klugman S, Xia LC, Gruber D, Tegay D, LaBella A, Onel K, Ostrer H, Prediction of breast cancer risk based on flow variant analysis of circulating peripheral blood mononuclear cells HGG advances3:100085 2021 |
PubMed ID: 35146455 |
|
Bhalla K, Jaber S, Reagan K, Hamburg A, Underwood KF, Jhajharia A, Singh M, Bhandary B, Bhat S, Nanaji NM, Hisa R, McCracken C, Creasy HH, Lapidus RG, Kingsbury T, Mayer D, Polster B, Gartenhaus RB, SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma Scientific reports10:21159 2020 |
PubMed ID: 33273545 |
|
Innes CL, Heinloth AN, Flores KG, Sieber SO, Deming PB, Bushel PR, Kaufmann WK, Paules RS, ATM requirement in gene expression responses to ionizing radiation in human lymphoblasts and fibroblasts. Mol Cancer Res4(3):197-207 2006 |
PubMed ID: 16547157 |
|
Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, Chadha M, Hui H, Yang G, Kennedy GC, Webster TA, Cawley S, Walsh PS, Jones KW, Fodor SP, Mei R, Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods1(2):109-11 2004 |
PubMed ID: 15782172 |
|
Deming PB, Cistulli CA, Zhao H, Graves PR, Piwnica-Worms H, Paules RS, Downes CS, Kaufmann WK, The human decatenation checkpoint. Proc Natl Acad Sci U S A98(21):12044-9 2001 |
PubMed ID: 11593014 |
|
Lin WC, Lin FT, Nevins JR, Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev15(14):1833-44 2001 |
PubMed ID: 11459832 |
|
Sasaki T, Tian H, Kukita Y, Inazuka M, Tahira T, Imai T, Yamauchi M, Saito T, Hori T, Hashimoto-Tamaoki T, Komatsu K, Nikaido O, Hayashi K, ATM mutations in patients with ataxia telangiectasia screened by a hierarchical strategy. Hum Mutat12(3):186-95 1998 |
PubMed ID: 9711876 |
|
Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB, DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev11:3471-81 1997 |
PubMed ID: 9407038 |
|
Chen G, Lee EYHP, The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J Biol Chem271:33693-7 1996 |
PubMed ID: 8969240 |
|
Taylor YC, Duncan PG, Zhang X, Wright WD, Differences in the DNA supercoiling response of irradiated cell lines from ataxia-telangiectasia versus unaffected individuals. Int J Radiat Biol59:359-71 1991 |
PubMed ID: 1671687 |
|
Taylor YC, Zhang XF, Parsian AJ, Duncan PG, Image analysis-based measurement of DNA supercoiling changes in transformed and nontransformed human cell lines. Exp Cell Res197:222-8 1991 |
PubMed ID: 1659987 |
|
Karam LR, Calsou P, Franklin WA, Painter RB, Olsson M, Lindahl T, Modification of deoxyribose-phosphate residues by extracts of ataxia telangiectasia cells. Mutat Res236:19-26 1990 |
PubMed ID: 2366795 |
|
Berliner N, Duby AD, Morton CC, Leder P, Seidman JG, Detection of a frequent restriction fragment length polymorphism in the human T cell antigen receptor beta chain locus. A potential diagnostic tool. J Clin Invest76:1283-5 1985 |
PubMed ID: 2995449 |
dbSNP |
dbSNP ID: 10640 |
Gene Cards |
ATM |
Gene Ontology |
GO:0003677 DNA binding |
|
GO:0003700 transcription factor activity |
|
GO:0004674 protein serine/threonine kinase activity |
|
GO:0005622 intracellular |
|
GO:0005634 nucleus |
|
GO:0006281 DNA repair |
|
GO:0006355 regulation of transcription, DNA-dependent |
|
GO:0007131 meiotic recombination |
|
GO:0007165 signal transduction |
|
GO:0016740 transferase activity |
|
GO:0016773 phosphotransferase activity, alcohol group as acceptor |
|
GO:0045786 negative regulation of cell cycle |
GEO |
GEO Accession No: GSM1116571 |
|
GEO Accession No: GSM1116572 |
|
GEO Accession No: GSM1116625 |
|
GEO Accession No: GSM1116626 |
|
GEO Accession No: GSM1116627 |
|
GEO Accession No: GSM1116628 |
|
GEO Accession No: GSM478631 |
|
GEO Accession No: GSM478632 |
|
GEO Accession No: GSM634849 |
|
GEO Accession No: GSM634850 |
|
GEO Accession No: GSM634851 |
|
GEO Accession No: GSM634855 |
|
GEO Accession No: GSM634856 |
|
GEO Accession No: GSM634857 |
|
GEO Accession No: GSM71344 |
|
GEO Accession No: GSM71345 |
|
GEO Accession No: GSM71346 |
|
GEO Accession No: GSM71347 |
|
GEO Accession No: GSM71348 |
|
GEO Accession No: GSM71349 |
|
GEO Accession No: GSM71350 |
|
GEO Accession No: GSM71351 |
NCBI Gene |
Gene ID:472 |
NCBI GTR |
208900 ATAXIA-TELANGIECTASIA; AT |
|
607585 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM |
OMIM |
208900 ATAXIA-TELANGIECTASIA; AT |
|
607585 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM |
Omim Description |
AT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED |
|
AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED |
|
AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED |
|
AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED |
|
AT1 |
|
ATAXIA-TELANGIECTASIA; AT |
|
LOUIS-BAR SYNDROMEATAXIA-TELANGIECTASIA MUTATED, INCLUDED; ATM, INCLUDED |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|